JP2023522023A5 - - Google Patents

Info

Publication number
JP2023522023A5
JP2023522023A5 JP2022562632A JP2022562632A JP2023522023A5 JP 2023522023 A5 JP2023522023 A5 JP 2023522023A5 JP 2022562632 A JP2022562632 A JP 2022562632A JP 2022562632 A JP2022562632 A JP 2022562632A JP 2023522023 A5 JP2023522023 A5 JP 2023522023A5
Authority
JP
Japan
Prior art keywords
morphology
shows
approximately
water vapor
eur
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022562632A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023522023A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2021/059604 external-priority patent/WO2021209477A1/en
Publication of JP2023522023A publication Critical patent/JP2023522023A/ja
Publication of JP2023522023A5 publication Critical patent/JP2023522023A5/ja
Pending legal-status Critical Current

Links

JP2022562632A 2020-04-17 2021-04-14 4-[(7-クロロ-2-メトキシベンゾ[b][1,5]ナフチリジン-10-イル)アミノ]-2,6-ビス(ピロリジン-1-イルメチル)フェノールおよびそれらの塩の結晶形態 Pending JP2023522023A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP20170197.6 2020-04-17
EP20170197 2020-04-17
PCT/EP2021/059604 WO2021209477A1 (en) 2020-04-17 2021-04-14 Crystalline forms of 4-[(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)amino]-2,6-bis(pyrrolidin-1-ylmethyl)phenol and salts thereof

Publications (2)

Publication Number Publication Date
JP2023522023A JP2023522023A (ja) 2023-05-26
JP2023522023A5 true JP2023522023A5 (https=) 2025-07-16

Family

ID=70333787

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022562632A Pending JP2023522023A (ja) 2020-04-17 2021-04-14 4-[(7-クロロ-2-メトキシベンゾ[b][1,5]ナフチリジン-10-イル)アミノ]-2,6-ビス(ピロリジン-1-イルメチル)フェノールおよびそれらの塩の結晶形態

Country Status (8)

Country Link
US (1) US20230295156A1 (https=)
EP (1) EP4136087A1 (https=)
JP (1) JP2023522023A (https=)
CN (1) CN115515955A (https=)
BR (1) BR112022018436A2 (https=)
CA (1) CA3175552A1 (https=)
PH (1) PH12022552366A1 (https=)
WO (1) WO2021209477A1 (https=)

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100975895B1 (ko) * 2008-04-29 2010-08-18 강민석 피로나리딘의 제조방법 및 이를 위한 중간체
CN101544638B (zh) * 2009-05-12 2012-05-30 重庆通天药业有限公司 乳酸咯萘啶及其药物组合物
CN103373995B (zh) * 2012-04-28 2016-04-27 上海迪赛诺药业有限公司 一种制备咯萘啶的方法
ES2902143T3 (es) * 2014-07-04 2022-03-25 Merck Patent Gmbh Derivados de azepanilo y composiciones farmacéuticas que los comprenden con actividad antiparasitaria
CN105461713A (zh) 2014-09-25 2016-04-06 刘力 苯并萘啶类的新化合物及其组合物和用途
JP2019530712A (ja) * 2016-10-13 2019-10-24 エムエムヴィ メディシンズ フォア マラリア ヴェンチャーMmv Medicines For Malaria Venture 新規抗マラリア薬
HUE069225T2 (hu) * 2018-04-11 2025-02-28 Merck Patent Gmbh Kinolin-4-karboxamidok és benzonaftiridin származékok kombinációja maláriaellenes gyógyszer-kombinációként
CN112209926A (zh) * 2019-07-12 2021-01-12 中国中医科学院中药研究所 磷酸咯萘啶的多晶型物及其制备方法、应用
CA3182616A1 (en) * 2020-06-15 2021-12-23 Lukas Shinji OKITSU Tlr7/8 antagonists and uses thereof

Similar Documents

Publication Publication Date Title
KR870000809B1 (ko) 1,4-디하이드로피리딘의 제조방법
AU2010241419B2 (en) Salts of 4-methyl-n-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)- benzamide
US8158607B2 (en) Crystalline form of lamivudine
US8518936B2 (en) Method for preparing acid addition salts of polyacidic basic compounds
IL208152A (en) Processes for the preparation of supernatant tosylate crystalline form iii, supernatant tosylate methanol solvate and supernatant tozylate ethanol solvate
US20110275690A1 (en) New crystal form of sunitinib malate
JP2013529639A (ja) ニロチニブ塩及びそれらの結晶性形態
WO2014060449A1 (en) Multicomponent crystalline system comprising nilotinib and selected co-crystal formers
JP6779972B2 (ja) 呼吸器合胞体ウイルス(rsv)感染症の処置のためのn−[(3−アミノ−3−オキセタニル)メチル]−2−(2,3−ジヒドロ−1,1−ジオキシド−1,4−ベンゾチアゼピン−4(5h)−イル)−6−メチル−4−キナゾリンアミンの結晶形
WO2011086541A1 (en) Novel polymorph of nilotinib monohydrochloride monohydrate
WO2011033307A1 (en) Nilotinib dihydrochloride salt
AU2009350978A1 (en) Lenalidomide salts
JP3539926B2 (ja) 抗ウイルス性ピリミジンジオン誘導体及びそれらの製造方法
JP2022526827A (ja) (e)-3-[2-(2-チエニル)ビニル]-1h-ピラゾールの固体形態
JP2003514859A5 (https=)
TW200900392A (en) Novel crystalline bepotastine metal salt hydrate, method for preparing same, and pharmaceutical composition comprising same
JP2023522023A5 (https=)
CN112624983A (zh) 一种含烷基结构的联苯二芳基嘧啶类衍生物及其制备方法和应用
JP2012500837A (ja) 新規な結晶型およびその調製方法
KR100830002B1 (ko) 시부트라민의 무기산염
KR20060080817A (ko) 시부트라민의 디카복실산염
JP5530369B2 (ja) 新規な結晶形
JP2008526835A (ja) シブトラミンのスルホン酸塩
KR102013566B1 (ko) 6-(피페리딘-4-일옥시)-2h-이소퀴놀린-1-온 하이드로클로라이드의 결정성 용매화물
JP2006500337A (ja) 塩酸ベナゼプリルの結晶多形形態および非晶質形態